Cargando…
Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen® requirements
BACKGROUND: Vitamin B12 deficiency may have deleterious effects on end stage renal disease (ESRD) patients on maintenance hemodialysis, and may increase erythropoietin stimulating agent (ESA) resistance, yet little is known about its prevalence in this population. METHODS: Serum vitamin B12 and meth...
Autores principales: | Saifan, Chadi, Samarneh, Mark, Shtaynberg, Norbert, Nasr, Rabih, El-Charabaty, Elie, El-Sayegh, Suzanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681404/ https://www.ncbi.nlm.nih.gov/pubmed/23776388 http://dx.doi.org/10.2147/IJNRD.S44660 |
Ejemplares similares
-
Variability in Response to Hepatitis B Vaccine in Hemodialysis Patients
por: El-Charabaty, Elie, et al.
Publicado: (2015) -
Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study
por: Saifan, Chadi, et al.
Publicado: (2013) -
Effect of hepatitis C virus infection on erythropoiesis in patients on hemodialysis
por: Saifan, Chadi, et al.
Publicado: (2013) -
Warfarin-induced calciphylaxis: a case report and review of literature
por: Saifan, Chadi, et al.
Publicado: (2013) -
Relationship between platelet count and hemodialysis membranes
por: Nasr, Rabih, et al.
Publicado: (2013)